logo
Share SHARE
FONT-SIZE Plus   Neg

Teleflex's VasoNova Gets CE Certification From BSI To Market Arrow VPS System

Teleflex Incorporated (TFX) Monday announced that the British Standards Institution, or the BSI, has granted CE certification to the company's subsidiary unit, VasoNova Inc to market the company's Arrow VPS system to the European Union.

Teleflex stated that marketing for this product in Europe would commence immediately.

The Arrow VPS system is the first to use a unique micro-Doppler ultrasound technology in combination with intravascular ECG and advanced algorithms to provide precise guidance to clinicians and enable correct placement of catheter tips the first time. Employing a simple user interface and blue bullseye symbol, the new technology is designed to avoid clinical consequences such as thrombosis, arterial puncture and vessel wall damage.

The company further that the Arrow VPS System is already available in the United States, and the company had been shipping this product to the hospitals across the U.S since January 2011.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of International Consolidated Airlines Group S.A. were gaining around 3 percent in London trading after the airline reported Friday higher profit in its second quarter, benefited by higher passenger revenues, despite weak cargo revenues. The company now expects low double digit percentage growth in pre-exceptional operating profit in 2016. Swiss banking giant UBS Group AG reported Friday a 14 percent decline in second quarter profit with weakness in net interest income. Looking ahead, the company said the difficult conditions continue to persist, yet the firm is well positioned to benefit from even a moderate improvement in conditions. UBS shares were gaining around 3 percent in the morning trading in Zurich. We are well into the third quarter and past the middle of the year and it is time to take stock of regulatory decisions awaiting some biotech stocks in August. Despite the uncertain macroeconomic environment, the markets have run up, with the S&P 500 Index making new highs session after session. Valuation concerns may keep traders at bay. However, the biotech space is a different cup of tea.
comments powered by Disqus
Follow RTT